(Q38357991)

2 September 2017

title

Organ damage in patients with incomplete lupus syndromes: from a Chinese academic center (English)

1 reference

2 September 2017

Zhen Chen

1

1 reference

2 September 2017

Meng-Tao Li

2

1 reference

2 September 2017

Dong Xu

3

1 reference

2 September 2017

Xiao-Mei Leng

4

1 reference

2 September 2017

Qian Wang

5

1 reference

2 September 2017

Xin-Ping Tian

6

1 reference

2 September 2017

Shang-Zhu Zhang

7

1 reference

2 September 2017

Yan Zhao

8

1 reference

2 September 2017

Xiao-Feng Zeng

9

1 reference

2 September 2017

publication date

18 February 2015

1 reference

2 September 2017

published in

Clinical Rheumatology

1 reference

2 September 2017

volume

34

1 reference

2 September 2017

issue

8

1 reference

2 September 2017

page(s)

1383-1389

1 reference

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2884-3

Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2884-3

Organ damage in high-risk patients with systemic and incomplete lupus syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2884-3

Outcome of incomplete systemic lupus erythematosus after 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2884-3

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2884-3

Chinese SLE Treatment and Research group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2884-3

Undifferentiated CTD: a wide spectrum of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2884-3

SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2884-3

Lupus organ damage: what is damaged in Asian patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2884-3

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2884-3

Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2884-3

Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2884-3

Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2884-3

The systemic lupus international collaborating clinics (SLICC) damage index: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2884-3

Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus--a 5-yr prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2884-3

Dramatic development of severe SLE in a patient with an incomplete disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-015-2884-3

Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT)

21 January 2018

1 reference

12 December 2020

Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation

1 reference

12 December 2020

Damage accrual in southern Chinese patients with systemic lupus erythematosus.

1 reference

12 December 2020

Undifferentiated connective tissue diseases (UCTD): simplified systemic autoimmune diseases

1 reference

12 December 2020

Assessment of damage in Korean patients with systemic lupus erythematosus.

1 reference

12 December 2020

Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes

1 reference

12 December 2020

Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus

1 reference

12 December 2020

The relationship between neuropsychiatric, clinical, and laboratory variables and quality of life of Chinese patients with systemic lupus erythematosus

1 reference

12 December 2020

Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD).

1 reference

12 December 2020

The rate and pattern of organ damage in late onset systemic lupus erythematosus

1 reference

12 December 2020

Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus

1 reference

12 December 2020

10.1007/S10067-015-2884-3

Identifiers

DOI

1 reference

2 September 2017

1 reference